Fighting the stranger - Antioxidant protection against endotoxin toxicity

Toxicology

Volumn 180, Issue 1, 2002, Pages 45-63

  Cadenas, Susana ^a   Cadenas, Ana M ^b  

^a INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Antioxidants; Endotoxin; Lipopolysaccharide; Nitric oxide; Reactive oxygen species; Septic shock

Indexed keywords

ANTIOXIDANT; BACTERIAL TOXIN; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN RECOGNITION; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL MEMBRANE; CARDIOVASCULAR SYSTEM; CELL DAMAGE; ENDOTOXEMIA; GENETIC TRANSCRIPTION; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CARDIOVASCULAR SYSTEM; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NF-KAPPA B; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; VITAMIN E;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0037201966     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00381-5     Document Type: Article

References (172)

1. 10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain. Pharmacol. Res. 43:2001;257-263.
2. Aderem A. Role of Toll-like receptors in inflammatory response in macrophages. Crit. Care Med. 29:2001;S16-S18.
3. Anderson K.V. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12:2000;13-19.
4. Anderson M.T., Staal F.J., Gitler C., Herzenberg L.A., Herzenberg L.A. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proc. Natl. Acad. Sci. USA. 91:1994;11527-11531.
5. Aruoma O.I., Halliwell B., Hoey B.M., Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Rad. Biol. Med. 6:1989;593-597.
6. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
7. Barja G. Oxygen radicals, a failure or a success of evolution? Free Rad. Res. Commun. 18:1993;63-70.
8. Bazil V., Horejsi V., Baudys M., Kristofova H., Strominger J.L., Kostka W., Hilgert I. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur. J. Immunol. 16:1986;1583-1589.
9. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271:1996;C1424-C1437.
10. Benito E., Bosch M.A. Impaired phosphatidylcholine biosynthesis and ascorbic acid depletion in lung during lipopolysaccharide-induced endotoxaemia in guinea pigs. Mol. Cell Biochem. 175:1997;117-123.
11. Ben-Shaul V., Lomnitski L., Nyska A., Zurovsky Y., Bergman M., Grossman S. The effect of natural antioxidants, NAO and apocynin, on oxidative stress in the rat heart following LPS challenge. Toxicol. Lett. 123:2001;1-10.
12. Beutler B. TLR4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 12:2000;20-26.
13. Blackwell T.S., Holden E.P., Blackwell T.R., Christman B.W., Christman J.W. Activation of NF-κB in rat lungs by treatment with endotoxin: modulation by treatment with N-acetylcysteine. J. Immunol. 157:1996;1630-1637.
14. Bolanos J.P., Peuchen S., Heales S.J., Land J.M., Clark J.B. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63:1994;910-916.
15. Borrelli E., Roux-Lombard P., Grau G.E., Girardin E., Ricou B., Dayer J., Suter P.M. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit. Care Med. 24:1996;392-397.
16. Borutaite V., Matthias A., Harris H., Moncada S., Brown G.C. Reversible inhibition of cellular respiration by nitric oxide in vascular inflammation. Am. J. Physiol. Heart Circ. Physiol. 281:2001;H2256-H2260.
17. Brennan P., O'Neill L.A. Effects of oxidants and antioxidants on nuclear factor-κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim. Biophys. Acta. 1260:1995;167-175.
18. Broner C.W., Shenep J.L., Stidham G.L., Stokes D.C., Fairclough D., Schonbaum G.R., Rehg J.E., Hildner W.K. Effect of antioxidants in experimental Escherichia coli septicemia. Circ. Shock. 29:1989;77-92.
19. Brown G.C. Reversible binding and inhibition of catalase by nitric oxide. Eur. J. Biochem. 232:1995a;188-191.
20. Brown G.C. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 369:1995b;136-139.
21. Brown G.C. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim. Biophys. Acta. 1504:2001;46-57.
22. Brown G.C., Bolanos J.P., Heales S.J.R., Clark J.B. NO produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci. Lett. 193:1995;1-4.
23. Cadenas S., Lertsiri S., Otsuka M., Barja G., Miyazawa T. Phospholipid hydroperoxides and lipid peroxidation in liver and plasma of ODS rats supplemented with alpha-tocopherol and ascorbic acid. Free Rad. Res. 24:1996;485-493.
24. Cadenas S., Rojas C., Barja G. Endotoxin increases oxidative injury to proteins in guinea pig liver: protection by dietary vitamin C. Pharmacol. Toxicol. 82:1998;11-18.
25. Chandel N.S., Trzyna W.C., McClintock D.S., Schumacker P.T. Role of oxidants in NF-κB activation and TNF-α gene transcription induced by hypoxia and endotoxin. J. Immunol. 165:2000;1013-1021.
26. Chen Z., Hagler J., Palombella V.J., Melandri F., Scherer D., Ballard D., Maniatis T. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1995;1586-1597.
27. Christman J.W., Lancaster L.H., Blackwell T.S. Nuclear factor-κB: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intens. Care Med. 24:1998;1131-1138.
28. Cobb J.P., Natanson C., Hoffman W.D., Lodato R.F., Banks S., Koev C.A., Solomon M.A., Elin R.J., Hosseini J.M., Danner R.L. N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J. Exp. Med. 176:(4):1992;1175-1182.
29. Connelly L., Palacios-Callender M., Ameixa C., Moncada S., Hobbs A.J. Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide. J. Immunol. 166:2001;3873-3881.
30. Darley-Usmar V., Wiseman H., Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. 369:1995;131-135.
31. Darveau R.P. Lipid A diversity and the innate host response to bacterial infection. Curr. Opin. Microbiol. 1:1998;36-42.
32. Denninger J.W., Marletta M.A. Guanylate cyclase and the NO/cGMP signalling pathway. Biochim. Biophys. Acta. 1411:1999;334-350.
33. Dwenger A., Pape H.C., Bantel C., Schweitzer G., Krumm K., Grotz M., Lueken B., Funck M., Regel G. Ascorbic acid reduces the endotoxin-induced lung injury in awake sheep. Eur. J. Clin. Invest. 24:1994;229-235.
34. Erl W., Weber C., Wardemann C., Weber P.C. Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-κB mobilization. Am. J. Physiol. 273:1997;H634-H640.
35. Essani N.A., Fisher M.A., Jaeschke H. Inhibition of NF-κB activation by dimethyl sulfoxide correlates with suppression of TNF-α formation, reduced ICAM-gene transcription, and protection against endotoxin-induced liver injury. Shock. 7:1997;90-96.
36. Evans T., Carpenter A., Kinderman H., Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ. Shock. 41:1993;77-81.
37. Evans T., Carpenter A., Silva A., Cohen J. Inhibition of nitric oxide synthase in experimental Gram-negative sepsis. J. Infect. Dis. 169:1994;343-349.
38. Faggioni R., Gatti S., Demitri M.T., Delgado R., Echtenacher B., Gnocchi P., Heremans H., Ghezzi P. Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema. J. Lab. Clin. Med. 123:1994;394-399.
39. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T., McMurray D., Smith D.E., Sims J.E., Bird T.A., O'Neil L.A. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:2001;78-83.
40. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., Packer L. Redox regulation of NF-kappa B activation. Free Rad. Biol. Med. 22:1997;1115-1126.
41. Furchgott R.F. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. Vanhoutte P.M., Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium. 1988;401-414 Raven Press, New York.
42. Galley H.F., Davies M.J., Webster N.R. Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Rad. Biol. Med. 20:1996;139-143.
43. Galley H.F., Howdle P.D., Walker B.E., Webster N.R. The effects of intravenous antioxidants in patients with septic shock. Free Rad. Biol. Med. 23:1997;768-774.
44. Geng Z., Rong Y., Lau B.H. S-allyl cysteine inhibits activation of nuclear factor-κB in human T cells. Free Rad. Biol. Med. 23:1997;345-350.
45. Ghafourifar P., Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett. 418:1997;291-296.
46. Ghosh S., Gifford A.M., Riviere L.R., Tempst P., Nolan G.P., Baltimore D. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell. 62:1990;1019-1029.
47. Ginn-Pease M.E., Whisler R.L. Optimal NF kappa B mediated transcriptional responses in Jurkat T cells exposed to oxidative stress are dependent on intracellular glutathione and costimulatory signals. Biochem. Biophys. Res. Commun. 226:1996;695-702.
48. Giulivi C., Poderoso J.J., Boveris A. Production of nitric oxide by mitochondria. J. Biol. Chem. 273:1998;11038-11043.
49. Gomez-Jimenez J., Salgado A., Mourelle M., Martin M.C., Segura R.M., Peracaula R., Moncada S. L-Arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit. Care Med. 23:1995;253-258.
50. Goode H.F., Cowley H.C., Walker B.E., Howdle P.D., Webster N.R. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit. Care Med. 23:1995;646-651.
51. Gundersen Y., Corso C.O., Leiderer R., Dorger M., Lilleaasen P., Aasen A.O., Messmer K. The nitric oxide donor sodium nitroprusside protects against hepatic microcirculatory dysfunction in early endotoxaemia. Intens. Care Med. 24:1998;1257-1263.
52. Gunnett C.A., Chu Y., Heistad D.D., Loihl A., Faraci F.M. Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase. Am. J. Physiol. 275:1998;H416-H421.
53. Haendeler J., Zeiher A.M., Dimmeler S. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur. J. Pharmacol. 317:1996;407-411.
54. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. third ed: 1999;1-936 Oxford University Press, New York.
55. 2 and nitric oxide in inducible nitric oxide synthase expression in macrophages. Nitric Oxide. 5:2001;504-513.
56. Harakeh S., Jariwalla R.J. NF-κB-independent suppression of HIV expression by ascorbic acid. AIDS Res. Hum. Retrovir. 13:1997;235-239.
57. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., Goyert S.M. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity. 4:1996;407-414.
58. Heller A.R., Groth G., Heller S.C., Breitkreutz R., Nebe T., Quintel M., Koch T. N-Acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients. Crit. Care Med. 29:2001;272-276.
59. Hennet T., Richter C., Peterhans E. Tumor necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells. Biochem. J. 289:1993;587-592.
60. Hinder F., Booke M., Traber L.D., Matsumoto N., Nishida K., Rogers S., Traber D.L. Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial natriuretic peptide. Crit. Care Med. 24:1996;131-136.
61. Hobbs A.J., Higgs A., Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu. Rev. Pharmacol. Toxicol. 39:1999;191-220.
62. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:1999;3749-3752.
63. Igarashi O., Yonekawa Y., Fujiyama-Fujihara Y. Synergistic action of vitamin E and vitamin C in vivo using a new mutant of Wistar-strain rats, ODS, unable to synthesize vitamin C. J. Nutr. Sci. Vitaminol. 37:1991;359-369.
64. Ignarro L.J., Byrns R.E., Wood K.S. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. Vanhoutte P.M., Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium. 1988;427-436 Raven Press, New York.
65. Irie T., Muta T., Takeshige K. TAK1 mediates an activation signal from Toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide-stimulated macrophages. FEBS Lett. 467:2000;160-164.
66. Jack R.S., Fan X., Bernheiden M., Rune G., Ehlers M., Weber A., Kirsch G., Mentel R., Furll B., Freudenberg M., Schmitz G., Stelter F., Schutt C. Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection. Nature. 389:1997;742-745.
67. Jaeschke H., Ho Y.S., Fisher M.A., Lawson J.A., Farhood A. Glutathione peroxidase-deficient mice are more susceptible to neutrophil-mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidative stress. Hepatology. 29:1999;443-450.
68. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
69. Kelly K.A., Hill M.R., Yuokhana K., Wanker F., Gimble J.F. Dimethyl sulfoxide modulates NF-κB and cytokine activation in lipopolysaccharide-treated murine macrophages. Infect. Immun. 62:1994;3122-3128.
70. Kheir-Eldin A.A., Motawi T.K., Gad M.Z., Abd-ElGawad H.M. Protective effect of vitamin E, beta-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. Int. J. Biochem. Cell Biol. 33:2001;475-482.
71. ω-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA. 87:1990;3629-3632.
72. Klebanoff S.J., Vadas M.A., Harlan J.M., Sparks L.H., Gamble J.R., Agosti J.M., Waltersdorph A.M. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136:1986;4220-4225.
73. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-258.
74. Koay M.A., Christman J.W., Segal B.H., Venkatakrishnan A., Blackwell T.R., Holland S.M., Blackwell T.S. Impaired pulmonary NF-kappaB activation in response to lipopolysaccharide in NADPH oxidase-deficient mice. Infect. Immunol. 69:2001;5991-5996.
75. Laflamme N., Rivest S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating Gram-negative bacterial cell wall components. FASEB J. 15:2001;155-163.
76. Lander H.M., Sehajpal P., Levine D.M., Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1993;1509-1516.
77. Laubach V.E., Shesely E.G., Smithies O., Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA. 92:1995;10688-10692.
78. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 86:1996;973-983.
79. Li H., Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J. Pathol. 190:2000;244-254.
80. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M.J., Oikawa M., Qureshi N., Monks B., Finberg R.W., Ingalls R.R., Golenbock D.T. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105:2000;497-504.
81. Liu S., Adcock I.M., Old R.W., Barnes P.J., Evans T.W. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 196:1993;1208-1213.
82. Lorente J.A., Landin L., De Pablo R., Renes E., Liste D. L-Arginine pathway in the sepsis syndrome. Crit. Care Med. 21:1993;1287-1295.
83. Ma Q., Kinneer K. Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor alpha induction in macrophages. J. Biol. Chem. 277:2002;2477-2484.
84. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K., Hutchinson N., et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1995;641-650.
85. Maestroni G.J. Melatonin as a therapeutic agent in experimental endotoxic shock. J. Pineal Res. 20:1997;84-89.
86. Makropoulos V., Bruning T., Schulze-Osthoff K. Selenium-mediated inhibition of transcription factor NF-κB and HIV-LTR promoter activity. Arch. Toxicol. 70:1996;277-283.
87. Manna S.K., Zhang H.J., Yan T., Oberley L.W., Aggarwal B.B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J. Biol. Chem. 273:1998;13245-13254.
88. Martinez J., Moreno J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 59:2000;865-870.
89. Matés J.M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology. 153:2000;83-104.
90. Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T. Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acid Res. 24:1996;2236-2242.
91. Medzhitov R., Janeway C.A. The Toll receptor family and microbial recognition. Trends Microbiol. 8:2000;452-456.
92. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptative immunity. Nature. 388:1997;394-397.
93. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C.A. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell. 2:1998;253-258.
94. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:1993;2005-2015.
95. Meyer M., Pahl H.L., Baeuerle P.A. Regulation of the transcription factors NF-κB and AP-1 by redox changes. Chem. Biol. Interact. 91:1994;91-100.
96. Mirochnitchenko O., Inouye M. Effect of overexpression of human Cu,Zn superoxide dismutase in transgenic mice on macrophage functions. J. Immunol. 156:1996;1578-1586.
97. Mirochnitchenko O., Prokopenko O., Palnitkar U., Kister I., Powell W.S., Inouye M. Endotoxemia in transgenic mice overexpressing human glutathione peroxidases. Circ. Res. 87:2000;289-295.
98. Muzio M., Natoli G., Saccani S., Levrero M., Mantovani A. Divergence of nuclear factor-κB and JNK/SAPK activation upstream the tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187:1998;2097-2101.
99. Muzio M., Polentarutti N., Bosisio D., Prahladan M.K., Mantovani A. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J. Leukoc. Biol. 67:2000;450-456.
100. Nathens A.B., Bitar R., Davreux C., Bujard M., Marshall J.C., Dackiw A.P., Watson R.W., Rotstein O.D. Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury. Am. J. Respir. Cell Mol. Biol. 17:1997;608-616.
101. Nava E., Palmer R.M., Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet. 338:1991;8782-8783.
102. G-monomethyl-L-arginine. J. Cardiovasc. Pharmacol. 20:1992;S132-S134.
103. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 398:1999;252-256.
104. Nolan G.P., Ghosh S., Liou H.C., Tempst P., Baltimore D. DNA binding and IκB inhibition of the cloned p65 subunit of NFκB, a rel-related polypeptide. Cell. 64:1991;961-969.
105. Offermann M.K., Lin J.C., Mar E.C., Shaw R., Yang J., Medford R.M. Antioxidant-sensitive regulation of inflammatory-response genes in Kaposi's sarcoma cells. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13:1996;1-11.
106. Ogilvie A.C., Groeneveld A.B., Straub J.P., Thijs L.G. Plasma lipid peroxides and antioxidants in human septic shock. Intens. Care Med. 17:1991;40-44.
107. Olas B., Wachowicz B., Saluk-Juszczak J., Zielinski T., Kaca W., Buczynski A. Antioxidant activity of resveratrol in endotoxin-stimulated blood platelets. Cell Biol. Toxicol. 17:2001;117-125.
108. Ortolani O., Conti A., De Gaudio A.R., Moraldi E., Cantini Q., Novelli G. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am. J. Respir. Crit. Care Med. 161:2000;1907-1911.
109. Packer L., Slater T.F., Willson R.L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature. 278:1979;737-738.
110. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
111. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
112. Parker J.L., Myers P.R., Zhong Q., Kim K., Adams H.R. Inhibition of endothelium-dependent vasoldilation by Escherichia coli endotoxemia. Shock. 2:1994;451-458.
113. Parratt J.R. Nitric oxide in sepsis and endotoxaemia. J. Antimicrob. Chemother. 41:1998;31-39.
114. Parrillo J.E. Pathogenetic mechanisms of septic shock. New Engl. J. Med. 328:1993;1471-1477.
115. Pattanaik U., Prasad K. Endotoxemia and oxidative stress. Ann. N.Y. Acad. Sci. 793:1996;506-510.
116. Pattanaik U., Prasad K. Reactive oxygen species and endotoxic shock: effect of dimethylthiourea. J. Cardiovasc. Pharmacol. Ther. 6:2001;273-285.
117. Peake S.L., Moran J.L., Leppard P.I. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit. Care Med. 24:1996;1302-1310.
118. Peng H.B., Libby P., Liao J.K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270:1995;14214-14219.
119. Perera P.Y., Vogel S.N., Detore G.R., Haziot A., Goyert S.M. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J. Immunol. 158:1997;4422-4429.
120. Peristeris P., Clark B.D., Gatti S., Faggioni R., Mantovani A., Mengozzi M., Orencole S.F., Sironi M., Ghezzi P. N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol. 140:1992;390-399.
121. Petros A., Bennett D., Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 338:1991;1557-1558.
122. Petros A., Lamb G., Leone A., Moncada S., Bennett D., Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28:1994;34-39.
123. Poderoso J.J., Carreras M.C., Lisdero C., Riobo N., Schopfer F., Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biophys. Biochem. 328:1996;85-92.
124. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
125. Poltorak A., Ricciardi-Castagnoli P., Citterio S., Beutler B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. USA. 97:2000;2163-2167.
126. Prasad K., Kalra J., Chaudhary A.K., Debnath D. Effect of polymorphonuclear leukocyte-derived oxygen free radicals and hypochlorous acid on cardiac function and some biochemical parameters. Am. Heart J. 119:1990;538-550.
127. Quezado Z.M.N., Karzai W., Danner R.L., Freeman B.D., Yan L., Eichacker P.Q., Banks S.M., Cobb J.P., Cunnion R.E., Quezado M.J.N., Sevransky J.E., Natanson C. Effects of L-NMMA and fluid loading on TNF-induced cardiovascular dysfunction in dogs. Am. J. Respir. Crit. Care Med. 157:1998;1397-1405.
128. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., Gros P., Malo D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:1999;615-625.
129. Radi R., Rodriguez M., Castro L., Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 308:1994;89-95.
130. Raetz C.R. Biochemistry of endotoxins. Annu. Rev. Biochem. 59:1990;129-170.
131. Rhee S.G. Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31:1999;53-59.
132. Rice N.R., Ernst M.K. In vivo control of NF-κB activation by IκBα EMBO J. 12:1993;4685-4746.
133. Rojas C., Cadenas S., Herrero A., Mendez J., Barja G. Endotoxin depletes ascorbate in the guinea pig heart. Protective effects of vitamins C and E against oxidative stress. Life Sci. 59:1996;649-657.
134. Salvemini D., Korbut R., Anggard E., Vane J. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 87:1990;2593-2597.
135. Schenk H., Klein M., Erdbrugger W., Droge W., Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA. 91:1994;1672-1676.
136. Schmidt N.K., Amstad P., Cerutti P., Baeuerle P.A. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-kappa B. Chem. Biol. 2:1995a;13-22.
137. Schmidt N.K., Traenckner E.B., Meier B., Baeuerle P.A. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-κB. J. Biol. Chem. 270:1995b;27136-27142.
138. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
139. Schreck R., Albermann K., Baeuerle P.A. Nuclear factor-κB: an oxidative stress-response transcription factor of eukaryotic cells (a review). Free Rad. Res. Commun. 17:1992a;221-237.
140. Schreck R., Meier B., Mannel N., Droge W., Baeuerle P.A. Dithiocarbamates act as potent inhibitors of nuclear factor-κB activation in intact cells. J. Exp. Med. 175:1992b;1181-1194.
141. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267:1992;5317-5323.
142. Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12:1993;3095-3104.
143. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., Tobias P.S., Ulevitch R.J. Structure and function of lipopolysaccharide binding protein. Science. 249:1990;1429-1431.
144. Sewerynek E., Melchiorri D., Chen L., Reiter R.J. Melatonin reduces both basal and bacterial lipopolysaccharyde-induced lipid peroxidation in vitro. Free Rad. Biol. Med. 19:1995;903-909.
145. Shaffer J.B., Treanor C.P., Del Vecchio P.J. Expression of bovine and mouse endothelial cell antioxidant enzymes following TNF-α exposure. Free Rad. Biol. Med. 8:1990;497-502.
146. Shiki Y., Meyrick B.O., Brigham K.L., Burr I.M. Endotoxin increases superoxide dismutase in cultured bovine pulmonary endothelial cells. Am. J. Physiol. 252:1987;C436-C440.
147. Spapen H., Zhang H., Demanet C., Vleminckx W., Vincent J.L., Huyghens L. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest. 113:1998;1616-1624.
148. Spies C.D., Reinhart K., Witt I., Meier-Hellmann A., Hannemann L., Bredle D.L., Schaffartzik W. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study. Crit. Care Med. 22:1994;1738-1746.
149. Sprong R.C., Aarsman C.J., van Oirschot J.F., van Asbeck B.S. Dimethylthiourea protects rats against Gram-negative sepsis and decreases tumor necrosis factor and nuclear factor-κB activity. J. Lab. Clin. Med. 129:1997;470-481.
150. Sprong R.C., Winkelhuyzen-Janssen A.M., Aarsman C.J., van Oirschot J.F., van der Bruggen T., van Asbeck B.S. Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. Am. J. Respir. Crit. Care Med. 157:1998;1283-1293.
151. Staal F.J., Roederer M., Herzenberg L.A., Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor-κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 87:1990;9943-9947.
152. Suzuki Y.J., Packer L. Inhibition of NF-κB activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 193:1993;277-283.
153. Suzuki Y.J., Aggarwal B.B., Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem. Biophys. Res. Commun. 189:1992;1709-1715.
154. Szabo C., Southan G.J., Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 91:1994;12472-12476.
155. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., Takeda K., Akira S. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity. 11:1999;443-451.
156. Thiemermann C., Ruetten H., Wu C.C., Vane J.R. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br. J. Pharmacol. 116:1995;2845-2851.
157. Titheradge M.A. Nitric oxide in septic shock. Biochim. Biophys. Acta. 1411:1999;437-455.
158. Ulevitch R.J., Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:1995;437-457.
159. Vallance P., Moncada S. Role of endogenous nitric oxide in septic shock. New Horiz. 1:1993;77-86.
160. Víctor V.M., De la Fuente M. N-Acetylcysteine improves in vitro the function of macrophages from mice with endotoxin-induced oxidative stress. Free Rad. Res. 36:2002;33-45.
161. Vincent J.L., Zhang H., Szabo C., Preiser J.C. Effects of nitric oxide in septic shock. Am. J. Respir. Crit. Care Med. 161:2000;1781-1785.
162. Wadsworth T.L., McDonald T.L., Koop D.R. Effects of Ginkgo biloba extract (Egb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochem. Pharmacol. 62:2001;963-974.
163. Wanecek M., Weitzberg E., Rudehill A., Oldner A. The endothelin system in septic and endotoxin shock. Eur. J. Pharmacol. 408:2000;1-15.
164. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Xu D., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
165. Williams M.J., Rodriguez A., Kimbrell D.A., Eldon E.D. The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J. 16:1997;6120-6130.
166. Wink D.A., Miranda K.M., Espey M.G., Pluta R.M., Hewett S.J., Colton C., Vitek M., Feelisch M., Grisham M.B. Mechanisms of the antioxidant effects of nitric oxide. Antioxidat. Redox Signal. 3:2001;203-213.
167. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
168. Wright C.E., Rees D.D., Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26:1992;48-57.
169. Wu C.C., Chiao C.W., Hsiao G., Chen A., Yen M.H. Melatonin prevents endotoxin-induced circulatory failure in rats. J. Pineal Res. 30:2001;147-156.
170. Yang R.B., Mark M.R., Gray A., Huang A., Xie M.H., Zhang M., Goddard A., Wood W.I., Gurney A.L., Godowski P.J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 395:1998;217-219.
171. Yu B., Wright S.D. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J. Biol. Chem. 271:1996;4100-4105.
172. Zhang H., Spapen H., Nguyen D.N., Benlabed M., Buurman W.A., Vincent J.L. Protective effects of N-acetyl-L-cysteine in endotoxemia. Am. J. Physiol. 266:1994;H1746-1754.